Wikipedia
Imagabalin
Imagabalin ( INN, USAN; PD-332,334) is a drug which acts as a ligand for the αδ subunit of the voltage-dependent calcium channel, with some selectivity for the αδ subunit over αδ. Under development by Pfizer as a pharmaceutical medication, it has demonstrated preclinical efficacy of anxiolytic, analgesic, hypnotic, and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder.